4886 logo

ASKA Pharmaceutical Holdings Co.,Ltd. Stock Price

TSE:4886 Community·JP¥55.8b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

4886 Share Price Performance

JP¥1,966.00
-93.00 (-4.52%)
JP¥1,966.00
-93.00 (-4.52%)
Price JP¥1,966.00

4886 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Undervalued with excellent balance sheet and pays a dividend.

2 Risks
3 Rewards

ASKA Pharmaceutical Holdings Co.,Ltd. Key Details

JP¥67.0b

Revenue

JP¥34.6b

Cost of Revenue

JP¥32.4b

Gross Profit

JP¥27.6b

Other Expenses

JP¥4.8b

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
Feb 02, 2026
167.88
48.36%
7.11%
17.4%
View Full Analysis

About 4886

Founded
1920
Employees
1632
CEO
Sohta Yamaguchi
WebsiteView website
www.aska-pharma-hd.co.jp

ASKA Pharmaceutical Holdings Co.,Ltd., through its subsidiaries, engages in the pharmaceutical, animal health, and other businesses in Japan. The company researches, develops, manufactures, and markets pharmaceutical products in the areas of endocrinology, obstetrics and gynecology, and urology; and researches, manufactures, imports, exports, and sells veterinary medicines, veterinary medical devices, feed and feed additives, reagents, agrochemicals, industrial chemicals, hygiene products, and food products and their raw materials. It is also involved in the clinical examination and biological testing activities; and offers quasi-drugs, food supplements, and medical devices. The company was founded in 1920 and is headquartered in Tokyo, Japan.

Recent 4886 News & Updates

ASKA Pharmaceutical HoldingsLtd's (TSE:4886) Shareholders Have More To Worry About Than Only Soft Earnings

Nov 20
ASKA Pharmaceutical HoldingsLtd's (TSE:4886) Shareholders Have More To Worry About Than Only Soft Earnings

Recent updates

No updates